Greg Jennings, LLC’s Quest Diagnostics DGX Stock Holding History

Greg Jennings, LLC’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$764K	Buy	+3,279	New	+$758K	0.54%	34

Other funds holding DGX

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return

Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

JGP Wealth Management Bend, Oregon $1.13B AUM 26% 1-Year Est. Return

Greg Jennings, LLC's DGX Position: Q3 2026 in Review

Greg Jennings, LLC opened a new position in Quest Diagnostics (DGX) in Q3 2026: 3,279 shares worth $764K. The stake represents 0.54% of the portfolio and ranks #34 among its holdings.

210 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

Greg Jennings, LLC held 3,279 shares of Quest Diagnostics worth $764K as of Q3 2026.
Quest Diagnostics was a new Greg Jennings, LLC position in Q3 2026.
Quest Diagnostics made up 0.54% of Greg Jennings, LLC's portfolio in Q3 2026, its #34 holding.
210 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Greg Jennings, LLC's 13F filing for Q3 2026, filed 19 Oct 2026.